AstraZeneca, Merck breast cancer treatment lands FDA approval
The agency has approved Lynparza for use in the US as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.
Archives for March 22, 2022
Pfizer to supply up to 4m COVID-19 treatment courses to UNICEF
The pharmaceutical company has agreed to provide its Paxlovid oral COVID-19 treatment to the global charity, covering 95 low- and middle-income countries.